ACCRETION PHARMA LIMITED

ACCPL

Small Cap | Pharmaceuticals
66.55
-3.04 (-4.36%)

Stock price as on 06 Feb 2026 at 15:22 PM

Accretion pharma limited share price update

As of the latest trading session, Accretion Pharma Limited share price is currently at ₹66.55, which is down by ₹-3.04 from its previous closing. Toda...

Accretion Pharma Limited stock performance

Today’s low

₹66.15

Today’s high

₹68.5

₹66.55

52 week low

₹53.8

52 week high

₹102.5

₹66.55
Open
₹68.50
Previous close
₹69.60
Share volume
20,400
Total traded value (Lakh)
₹13.58
Upper circuit
₹73.05
Lower circuit
₹66.15

Accretion Pharma Limited fundamentals

Market cap (Cr)
₹74.00
P/E ratio (TTM)
11.39
Book value per share
₹40.51
Beta
0.69
Return on equity
65.35%
Earnings per share (TTM)
₹6.11
Dividend yield
0%
Net profit/quarter (Cr)
₹0.00

Accretion Pharma Limited financials

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹57.38

Operating expense

₹47.71

Net income

₹6.79

Net profit margin

11.83%

Earning per share

₹8.48

EBITDA

₹11.96

Effective tax rate

30.43%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹13.35

Operating expense

₹11.41

Net income

₹1.49

Net profit margin

11.16%

Earning per share

₹1.96

EBITDA

₹2.62

Effective tax rate

25%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹29.38

Operating expense

₹29.40

Net income

₹0.10

Net profit margin

0.34%

Earning per share

₹0.27

EBITDA

₹2.14

Effective tax rate

21.42%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹22.29

Operating expense

₹22.48

Net income

₹0.08

Net profit margin

0.35%

Earning per share

₹0.25

EBITDA

₹1.93

Effective tax rate

30%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹18.71

Return on Equity (ROE)

65.35%

Return on Capital Employed (ROCE)

46.32%

Total debt to equity ratio

1.33

EBITDA margin

20.88%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹13.73

Return on Equity (ROE)

27.14%

Return on Capital Employed (ROCE)

12.6%

Total debt to equity ratio

2.46

EBITDA margin

19.63%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹0.05

Total assets

₹39.87

Total liabilities

₹39.87

Total equity

₹15.28

Shares outstanding

₹0.81

Price to book ratio

-

Return on assets (%)

17.03%

Return on capital

23.12%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹0.09

Total assets

₹26.86

Total liabilities

₹26.86

Total equity

₹5.49

Shares outstanding

₹0.40

Price to book ratio

-

Return on assets (%)

5.55%

Return on capital

7.87%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹9.76

Cash from operations

₹7.60

Cash from investing

-₹1.61

Cash from financing

-₹4.18

Net change in cash

-₹0.04

Free cash flow

₹9.21

Particulars

Mar 24 (₹ value in crores)

Net income

₹1.99

Cash from operations

-₹12.29

Cash from investing

-₹5.47

Cash from financing

₹17.07

Net change in cash

₹0.09

Free cash flow

-₹6.81

Accretion Pharma Limited technical summary

₹66.6
-4.31 ▼
1
Bearish
15
Bullish
5 Day70.5
10 Day70.1
12 Day70.3
20 Day72
26 Day73.2
50 Day75.1
100 Day73.8
200 Day69.3
5 Day70.6
10 Day68.6
12 Day68.1
20 Day70.4
26 Day73.9
50 Day81.8
100 Day71.9
200 Day0

70.07

PIVOT

First support
₹69.13
First resistance
₹70.53
Second support
₹68.67
Second resistance
₹71.47
Third support
₹67.73
Third resistance
₹71.93
RSI
42.94
ADX
69.39
MACD
-2.98
Williams % R
-38.02
Commodity Channel Index (CCI)
-9.44
Date
05 Feb 2026
Same day
2,400
Week
5,000
Month
12,600
1 year
0.69
3 years
0.69
Over 1 month
-19.72%
Over 1 year
-16.09%
Over 3 months
26.2%
Over 3 years
0%
Over 6 months
17.36%
Over 6 years
0%

Investment Returns

Over 1 Month19.72%
Over 3 Months26.2%
Over 6 Months17.36%
Over 1 Year16.09%

Accretion Pharma Limited Shareholding pattern


Public
26.48%
Promoter holdings
73.51%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Mayur Popatlal Sojitra

19,66,500 (17.69%)

Shareholding of Promoter and Promoter Group

Hardik Mukundbhai Prajapati

19,66,500 (17.69%)

Shareholding of Promoter and Promoter Group

Vivek Ashok Kumar Patel

19,66,500 (17.69%)

Shareholding of Promoter and Promoter Group

Harshad Nanubhai Rathod

19,66,500 (17.69%)

Shareholding of Promoter and Promoter Group

Rajindra Valsalan

1,26,000 (1.13%)

Public Shareholding

Promoter sharesShareCategory
Mayur Popatlal Sojitra19,66,500 (17.69%)Shareholding of Promoter and Promoter Group
Hardik Mukundbhai Prajapati19,66,500 (17.69%)Shareholding of Promoter and Promoter Group
Vivek Ashok Kumar Patel19,66,500 (17.69%)Shareholding of Promoter and Promoter Group
Harshad Nanubhai Rathod19,66,500 (17.69%)Shareholding of Promoter and Promoter Group
Rajindra Valsalan1,26,000 (1.13%)Public Shareholding
Shweta Sojitra76,000 (0.68%)Shareholding of Promoter and Promoter Group
Vaishaki Hardik Prajapati76,000 (0.68%)Shareholding of Promoter and Promoter Group
Pooja Harshad Rathod76,000 (0.68%)Shareholding of Promoter and Promoter Group
Ankita Vivek Patel76,000 (0.68%)Shareholding of Promoter and Promoter Group
Rekhaben Karshandas Ghetiya2,400 (0.02%)Shareholding of Promoter and Promoter Group

About ACCRETION PHARMA LIMITED

Accretion Pharmaceuticals was incorporated in year 2012, the Promoters Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati, came together to establish a pharmaceutical manufacturing unit, to provide health care products. Thus, the foundation of 'Accretion Pharmaceuticals' was laid down, which was started as a Partnership Firm in the name of 'M/s Accretion Pharmaceuticals', pursuant to a deed of partnership dated December 18, 2012. The manufacturing facility which is curren

Parent Organisation

Indian Private

NSE Symbol

ACCPL

Founded

2023

ACCRETION PHARMA LIMITED CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)